Recently, a few large observational studies based upon in- and outpatient electronic health records [26–28] examined the association between antihypertensive medications and the risk of COVID-19 and/or a severe/lethal disease: our results are in line with most of the previous findings on an absence of risk with ACE inhibitors and/or ARBs use. This evidence concerns the gene ACE and COVID-19.